Sodium-glucose Co-transporter-2 inhibitors (SGLT2I): A class of drugs with promising cardiorenal protective effects beyond glycemic control

Diabetes Mellitus is always associated with both microvascular and macrovascular complications. Cardiovascular and renal complications are the leading cause of morbidity and mortality in these populations. Sodium-glucose co-transporter 2 inhibitors are a new class of antidiabetic drugs. These drugs...

Descripción completa

Detalles Bibliográficos
Autores principales: Zaawari, Abdullah, Sahar, Aaminah Najmus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486725/
https://www.ncbi.nlm.nih.gov/pubmed/36147162
http://dx.doi.org/10.1016/j.amsu.2022.104536

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486725/
https://www.ncbi.nlm.nih.gov/pubmed/36147162
http://dx.doi.org/10.1016/j.amsu.2022.104536

Ejemplares similares